Highest-materiality recent filing
Evolv Q2 revenue up 34% to $43.8M; raises FY2026 revenue and ARR guidance
Q2 revenue $43.8M, up 34% YoY; net loss narrowed to $(9.3)M from $(40.5)M a year ago
Evolv settles stockholder derivative suits; court preliminarily approves governance reforms
Court preliminarily approved derivative settlement on Aug 6, 2026; final approval hearing set for Oct 21, 2026.
Evolv annual meeting elects Glat and Shapiro as directors; say-on-pay and PwC ratified
Neil Glat and Richard Shapiro elected as Class II directors with ~75.7M and ~71.8M votes for, respectively.
Evolv corrects misreported Q1 rev; actual $46.3M (+45% YoY), FY guide $175-180M
Q1 2026 total revenue $46.3M, +45% vs $32.0M in Q1 2025.
Evolv Technology Q1 revenue $46.3M (+45% YoY); raises 2026 revenue outlook to $175-180M
Q1 revenue $46.3M, up 45% YoY from $32.0M; ARR $127.3M, up 20% YoY.
Evolv Tech Q4 net income $10.9M, revenue up 32%; raises 2026 outlook
Q4 revenue $38.5M (+32% YoY); net income $10.9M vs loss of $15.7M in Q4 2024.
Evolv Tech appoints Henrik Kühl to board; Bilal Zuberi resigns after 13 years
Henrik Kühl, SVP Strategy & Corp Dev at Axon, appointed to board and audit committee effective Feb 12, 2026.
Evolv Tech Q3 rev $42.9M (+57%), net loss narrows to $1.8M; raises 2025 outlook to $142-145M
Q3 revenue $42.9M (+57% YoY); net loss $(1.8)M vs $(30.4)M YoY.
Evolv Q2 rev $32.5M (+29% YoY), raises FY25 rev outlook to $132-135M
Q2 revenue $32.5M (+29% YoY); net loss $(40.5)M vs net income $3.4M in Q2'24 (restated).
Evolv Technology secures $75M credit facility with MidCap Financial; $30M drawn at close
$75M credit: $30M term loan drawn, $30M delayed draw, $15M revolver, 5-yr maturity.
Evolv files post-effective amendment to shelf registration, converting S-3 to S-1 after restatement
Filing is procedural; does not register any additional securities.
Kevin Charlton, John Kedzierski, Kimberly Sheehy, Bilal Zuberi elected as Class I directors with 80.5M to 73.0M votes for.
Evolv Tech Q1 revenue $32M (+44% YoY); guides FY2025 $125-130M, positive Adj. EBITDA
Q1'25 revenue $32.0M (up 44% YoY); Annual Recurring Revenue $106.0M (up 34% YoY).
Evolv completes restatement, reports Q4 revenue $29.1M (+41% YoY) and positive adjusted EBITDA $0.4M
Restatement corrects $3.1M net revenue recognition errors from Q2'22 to Q2'24; company regains SEC and Nasdaq compliance.
Evolv Technology appoints Chris Kutsor as CFO; $425K salary, $3.5M equity awards
Appointment effective one business day after filing 2024 10-K; succeeds interim CFO Dave Rawden.
Evolv gets Nasdaq delinquency notice for delayed 10-K due to sales probe
Received Nasdaq delinquency notice on Apr 16, 2025 for failing to file 2024 10-K on time.
Evolv Technology appoints Richard Shapiro to Board, effective Feb 3, 2025
Shapiro appointed as Class II director, will serve on Audit Committee; term until 2026 annual meeting.
Evolv Tech: CCO Jay Muelhoefer departs Feb 7; hires ex-Motorola exec Robert Marshall as CRO
Jay Muelhoefer to leave as CCO effective Feb 7, 2025; eligible for severance under company plan.
Evolv cuts 14% workforce; reports Q4 deployments of 6,000+ Express units and 470 new subscriptions
Reduction in force of 40 employees (14% of workforce); expects $2.3M pre-tax charges, $9M annualized cash savings.
Director Merline Saintil resigns from board; Kevin Charlton to fill Audit Committee seat
Merline Saintil informed board of resignation effective January 15, 2025.
Director Peter George resigns from Evolv Technologies Board, effective Dec 10, 2024
Peter George resigned from the Board of Directors effective immediately on December 10, 2024.
Evolv Technology appoints John Kedzierski as CEO, President, and Director effective Dec 16
John Kedzierski, former Motorola Solutions SVP, appointed CEO, President, and Class I Director effective Dec 16.
Evolv receives Nasdaq delinquency notice for late Q3 10-Q, cites sales practice investigation
Nasdaq notice for delayed Q3 2024 10-Q; must submit compliance plan by Jan 20, 2025.
Investigation found $4M–$6M net premature/incorrect revenue recognition through June 30, 2024; cash $56M, no debt.
Evolv Technologies terminates CEO Peter George; names co-founder Michael Ellenbogen as interim CEO
Peter George terminated without cause effective Oct 30, 2024; eligible for severance under existing plan.
Evolv Technology restates financials from Q2 2022 to Q2 2024; premature revenue of $4-6M
Board determines previously issued financials for periods Q2 2022 through Q2 2024 should not be relied upon due to revenue recognition errors.
Evolv Technologies reports Q2 2024 results; specifics not provided in filing
Financial results for quarter ended June 30, 2024 announced August 8, 2024.
Evolv shareholders reject officer exculpation amendment at annual meeting
Elected Class III directors Ellenbogen, George, and Naik with 81-95% of votes cast.
Evolv Technologies reports Q1 2024 results; no figures in filing
Press release furnished as Exhibit 99.1 but full content not provided in this input.
Evolv Technologies announces Q4/FY2023 results; filing lacks specific financial data
Company reported results for quarter and year ended Dec 31, 2023, but press release text is not included in this 8-K.
Evolv Technologies discloses SEC non-public fact-finding inquiry received Feb. 16
SEC notified Evolv on Feb. 16, 2024 of a confidential non-public fact-finding investigation.
Adopted amendments to Amended and Restated Bylaws regarding universal proxy rules, requiring compliance with Rule 14a-19.
Evolv Technologies announces Q3 2023 results but no specific figures in filing
Filed 8-K reporting results for nine months ended September 30, 2023.
Evolv directors Kedzierski, Cohen resign; Naik, Gonzales appointed; Glat named Chairman
John Kedzierski (Motorola designee) and Chairman Alan Cohen resign from board effective Nov 2, 2023.
Evolv Technologies restates Q2 2023 financials on treasury bill classification error
Restatement reclassifies $29.6M from cash equivalents to marketable securities as of June 30, 2023.
Evolv Tech raises FY 2023 outlook; discloses FTC inquiry into marketing practices
Preliminary Q3 revenue $19.3-19.8M, ARR $65.5-66.0M, gross margin 56-57%.
Evolv Technologies announces H1 2023 financial results (details not in excerpt)
Company reported results for six months ended June 30, 2023, via press release.
Evolv Technologies stockholders elect four Class II directors, ratify PwC
Alan Cohen, Neil Glat, Merline Saintil, and Mark Sullivan elected as Class II directors with 68.6M-76.9M votes for each.
Evolv Technologies reports Q1 2023 results; specific figures not provided in filing excerpt
Company announced financial results for three months ended March 31, 2023 on May 10, 2023.
Evolv repays $29.3M SVB loan, triggers default; Delaware court validates charter amendment
Repaid $29.3M principal, $0.2M interest, and 1% prepayment fee on 2022 SVB Credit Agreement; agreement terminated.
Evolv files Delaware court petition to validate charter and shares after Boxed ruling
Filed March 14, 2023 petition under DGCL Section 205 to validate Second Amended Certificate increasing authorized Class A shares to 1.1B.
Evolv Technologies adopts executive bonus plan, amends CFO severance, rebalances board
Compensation Committee adopted Executive Officer Performance Bonus Plan under 2021 Incentive Award Plan; bonuses based on corporate/individual performance goals.
Evolv Technologies reports Q4 and FY2022 results; no financial details in filing text
Announced financial results for the three and twelve months ended December 31, 2022.
Evolv Technology closes $75M non-dilutive debt facility with Silicon Valley Bank
Initial $30M term loan drawn at close; up to $20M additional (or $25M with conditions) within 18 months.
Evolv Technologies reports Q3 2022 results; no specific figures provided in filing excerpt
Evolv announced financial results for Q3 and nine months ended September 30, 2022 via press release.
Evolv Technologies Holdings approves severance plan; CEO, CFO get 12-18 months pay
Severance Plan approved Oct 25, effective Jan 1, 2023; covers VPs and above including named execs.
David Orfao, Class I Director and Compensation Committee member, resigned effective Sept 2, 2022, with no disagreement.
Evolv reports Q2 2022 results; press release details not in filing
Evolv announced quarterly results on August 10, 2022.
Evolv shareholders elect three Class I directors, ratify PwC as auditor
Kevin Charlton, David Orfao, and Bilal Zuberi each received over 67.5M FOR votes to serve as Class I directors until 2025.
Evolv Technology appoints Mark Donohue as CFO; Mario Ramos resigns effective May 31
CFO Mario Ramos resigns effective May 31, 2022, to become CEO of a private financial services company.
On the Effective Date, Mr. Kutsor will succeed Dave Rawden from AlixPartners LLP, a leading global business advisory firm, who has served as the Company’s Interim Chief Financial Officer since November 20, 2024.
On April 23, 2025, Evolv Technologies Holdings, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed George C. Kutsor as the Company’s new Chief Financial Officer on April 21, 2025, to be effective one business day following the filing of the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2024 (the “Effective Date”).
On January 31, 2025, the Board of Directors (the “Board”) of Evolv Technologies Holdings, Inc. (the “Company”) appointed Richard Shapiro to the Company’s Board, effective February 3, 2025, to serve as a Class II director until the Company’s 2026 annual meeting of stockholders.
on January 21, 2025, Evolv Technologies Holdings, Inc. (the “Company”) decided to make a leadership change and Jay Muelhoefer will no longer serve as the Chief Commercial Officer of the Company, effective February 7, 2025.
On such date, the Company’s board of directors (the “Board”) also appointed Dave Rawden from AlixPartners LLP (“AlixPartners”), a leading global business advisory firm, as Interim Chief Financial Officer, and designated him as principal financial officer and principal accounting officer.
On November 20, 2024, Mark Donohue, the Chief Financial Officer and principal financial officer and principal accounting officer of Evolv Technologies Holdings, Inc. (the “Company”), resigned effective November 21, 2024.
terminated Peter George, President and Chief Executive Officer of the Company without cause, effective immediately.
appointed Michael Ellenbogen, the Company’s Chief Innovation Officer and a member of the Board, as Interim President and Chief Executive Officer
On October 31, 2023, Alan Cohen notified the Board of his intention to step down as Chairman of the Board and as a Class II director of the Board, including as a member of the Board’s Nominating and Corporate Governance Committee and Technology Committee, effective November 2, 2023.
On November 2, 2023, the Board, upon the recommendation of the Board’s nominating and corporate governance committee, and pursuant to the Stockholder Agreement, appointed Rajan Naik, as Motorola’s designee to fill the vacancy created by Mr. Kedzierski’s resignation to serve as a Class III director of the Board for a term ending at the 2024 annual meeting of stockholders of the Company, effective November 2, 2023.
On October 31, 2023, John Kedzierski, previously designated to serve on the Board of Directors (the “Board”) of Evolv Technologies Holdings, Inc. (the “Company”), pursuant to that certain Stockholder Agreement (the “Stockholder Agreement”) between NewHold Investment Corp. and Motorola Solutions, Inc. (“Motorola”), notified the Board of his intention to step down from the Board, effective November 2, 2023.
On November 2, 2023, the Board, upon the recommendation of the Board’s nominating and corporate governance committee, appointed David Mounts Gonzales, to serve as a Class II director of the Board and a member of the audit committee of the Board for a term ending at the 2026 annual meeting of stockholders of the Company, effective November 2, 2023.
Max materiality 0.90 · Median 0.55 · Most common event earnings